10.06.2024 14:01:53 - dpa-AFX: *ABBOTT GETS FDA CLEARANCE FOR TWO NEW OVER-THE-COUNTER CONTINUOUS GLUCOSE MONITORING SYSTEMS

Copyright(c) 2024 RTTNews.com. All Rights Reserved

Copyright RTT News/dpa-AFX
Name WKN Börse Kurs Datum/Zeit Diff. Diff. % Geld Brief Erster Schluss
Abbott Laboratories 850103 NYSE 100,070 18.07.24 22:00:35 -4,610 -4,40% 100,000 100,240 102,390 104,680

© 2000-2024 DZ BANK AG. Bitte beachten Sie die Nutzungsbedingungen | Impressum
2024 Infront Financial Technology GmbH